DermaSensor™
AI-Powered Skin Cancer Screening
Embedded Files
1 Room. 20 Programs. 100% Medicare Eligible.
Cancer Screening (Skin)
DTC proudly introduces DermaSensor™, the first and only FDA-cleared, AI-powered device for real-time, non-invasive skin cancer screening, exclusively available to Primary Care Providers (PCPs), without the need for biopsies. Skin cancer affects 1 in 5 Americans over their lifetime, making early detection crucial. Specifically designed to identify the three most common types of skin cancer—melanoma, basal cell carcinoma, and squamous cell carcinoma. Delivering fast, painless assessments in just seconds, DermaSensor™ enhances early detection capabilities and improves patient outcomes. By empowering providers with this advanced tool, DermaSensor™ enables proactive, life-saving care for patients at risk.
DermaSensor™ enhances primary care efficiency by providing a fast, non-invasive, and AI-powered skin cancer assessment, enabling early detection without the need for biopsies.
AI Skin Cancer Device Podcast
23:08 Minutes
Note: 15 second audio delay after pressing play.
Listen and Discover
The Primary Care Setting
The DermaSensor™ device is an innovative FDA-cleared, AI-powered handheld device designed to empower primary care providers (PCPs) in the early detection of skin cancer. Each screening conducted with the device generates a clear, color-coded report, allowing PCPs to quickly and easily interpret the results for individual patients. The device also includes integrated software that tracks the number of screenings performed, complete with time stamps, ensuring accurate record-keeping and facilitating streamlined patient management.
It is well known that access to dermatologists for the diagnosis and treatment of skin cancer remains a significant challenge, with nearly 40% of the U.S. population living in areas where dermatologic care is limited or unavailable. This shortage disproportionately affects rural and underserved communities, leaving many patients without timely evaluation and increasing their risk of advanced disease. In this context, PCPs play a critical role in bridging the gap in care by serving as the first line of defense in detecting skin cancers early.
Early detection is essential for improving patient outcomes, as identifying skin malignancies at an initial stage significantly reduces morbidity and mortality. Additionally, it alleviates the financial burden on both patients and the healthcare system by preventing the high costs associated with late-stage treatments. By equipping PCPs with accessible, efficient, and accurate diagnostic tools like DermaSensor™, the healthcare system can empower providers to enhance skin cancer screening capabilities and deliver timely care to a broader population.
This groundbreaking technology not only improves diagnostic confidence but also increases access to early detection, particularly in areas with limited specialist availability. By enabling earlier interventions and reducing the need for unnecessary referrals, the DermaSensor™ device contributes to better patient outcomes and significant reductions in overall healthcare costs.
Skin Cancer Affects 1 in 5 Americans
Cutting-Edge Technology
By integrating DermaSensor's cutting-edge elastic scattering spectroscopy (ESS) and artificial intelligence (AI), this innovative device enables non-invasive, real-time evaluation of suspicious skin lesions, helping to bridge the gap between primary care and dermatology. Unlike traditional diagnostic methods that often require biopsies or specialist referrals, DermaSensor™ provides an immediate, objective assessment within a primary care setting, streamlining workflow, reducing unnecessary procedures, and improving access to early skin cancer detection for patients. Its compact, user-friendly design makes it easy to integrate into routine clinical practice, allowing PCPs to confidently assess lesions and make informed decisions about further evaluation or referral. Know Now.
Non-Invasive Spectroscopy: DermaSensor™ employs elastic scattering spectroscopy (ESS) to analyze cellular and subcellular structures of skin lesions. By emitting light onto the skin and measuring the scattered light, it evaluates tissue morphology without the need for invasive procedures.
AI-Powered Analysis: The device integrates artificial intelligence algorithms to provide immediate, objective assessments of skin lesions, aiding physicians in making informed decisions about potential malignancies.
User-Friendly Design: Designed for ease of use, DermaSensor's handheld form factor allows seamless integration into routine clinical workflows, enabling quick assessments during patient consultations.
Identify Skin Cancer in Seconds
Identify Skin Cancer in Seconds
Elastic Scattering Spectroscopy (ESS) and Artificial Intelligence (AI) analyzes how light interacts with cellular structures to detect abnormalities of skin lesions for early cancer detection.
Skin Healthcare: Game Changer
Skin Healthcare: Game Changer
How does 'skincare' differ from 'skin healthcare'? The difference between skincare and skin healthcare lies in their focus and approach:
Skincare (aestheticians) – refers to the external care and maintenance of the skin through products like cleansers, moisturizers, serums, sunscreens, and treatments. It focuses on cosmetic improvements, such as hydration, anti-aging, and acne control.
Skin healthcare (medical provider) – considers both internal and external perspective of the overall well-being and function of skin wellness. It takes a comprehensive, medical-based approach to skin wellness, incorporating treatments, lifestyle interventions, and diagnostic assessments to prevent skin cancer, strengthen the skin barrier, and manage metabolic conditions like diabetes-related skin issues. Unlike traditional skincare, which primarily focuses on aesthetics, skin healthcare integrates both cosmetic and medical aspects to ensure the skin remains healthy, functional, and resilient, supporting long-term well-being beyond surface-level appearance.
In short, skincare is about routine and maintenance. While skin healthcare is about both internal and external or the overall well-being and function. Both are connected, but true skin health goes beyond cosmetic concerns to address the underlying biological and medical factors that keep skin functioning properly.
With the increasing prevalence of skin cancer (1 in 5 people), metabolic skin disorders, and inflammation-related conditions, integrating skin healthcare into primary care offers significant benefits—an approach already embraced by medical aesthetics clinics and functional medicine providers, who combine preventative, regenerative, and integrative dermatology to enhance overall skin wellness. While DermaSensor™ itself is not cleared for aesthetic or routine risk assessments, the integration of AI-powered skin analysis devices presents a valuable opportunity for primary care clinics offering concierge skincare solutions, med spas, and aesthetic practices to provide advanced skin health evaluations. These cutting-edge technologies seamlessly bridge the gap between medical-grade skin assessments and aesthetic care, enabling practitioners to deliver personalized, data-driven insights that enhance both preventive and corrective skincare strategies. By leveraging AI-driven analysis, clinics can offer more precise treatment recommendations, improve patient outcomes, and elevate the overall client experience in the rapidly evolving aesthetics industry.
This not only improves patient outcomes but also fosters trust, engagement, and loyalty by offering a highly customized experience. Beyond clinical benefits, AI-powered skin evaluations create new revenue streams by adding a premium, tech-forward dimension to aesthetic services. Whether through membership-based skin monitoring programs or pre-treatment risk assessments these technologies cater to the growing demand for proactive and personalized skin health management.
With consumer interest in high-tech, results-driven skincare at an all-time high, integrating AI-powered skin analysis positions clinics and medical spas at the forefront of innovation—offering clients an exclusive, science-backed approach to skin health and aesthetic optimization.
AI Skin Healthcare is the Future for PCP Clinics
Simple Solutions
Simple Solutions
Page updated
Report abuse